Salem Radio Network News Sunday, September 26, 2021

Business

Bayer raises outlook after strong Q2

FRANKFURT (Reuters) – Bayer on Thursday lifted its outlook for 2021, citing double digit growth rates at all divisions during the second-quarter, most notably its pharmaceuticals unit.

Core earnings before special items are now expected to come in at 10.6 billion to 10.9 billion euros ($12.6-$12.9 billion), up from a previous forecast for 10.5 billion to 10.8 billion.

($1 = 0.8450 euros)

(Reporting by Christoph Steitz; Editing by Tomasz Janowski)

Previous
Next

Editorial Cartoons

View More »

Gary Varvel
Mon, Sep 13, 2021

X CLOSE